Heron Therapeutics Inc (OQ:HRTX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HRTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Tang Kevin C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 14/20 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Dec 31/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -297,714  
Feb 14/20 Dec 31/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -121,500  
Feb 14/20 Dec 27/19 Quart Barry D Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -6,584  
Feb 14/20 Dec 27/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -41,189  
Feb 14/20 Dec 23/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -201,000  
Feb 14/20 Dec 23/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -80,400  
Feb 14/20 Dec 19/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -20,402  
Feb 14/20 Dec 19/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -20,402  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HRTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Dec 27/19 Quart Barry D Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -6,584  
Feb 14/20 Dec 31/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -297,714  
Feb 14/20 Dec 31/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -121,500  
Feb 14/20 Dec 27/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -41,189  
Feb 14/20 Dec 23/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -201,000  
Feb 14/20 Dec 23/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -80,400  
Feb 14/20 Dec 19/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -20,402  
Feb 14/20 Dec 19/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -20,402  
Feb 14/20 Aug 13/19 Tang Kevin C Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -230,000  
Feb 14/20 Feb 14/20 Tang Kevin C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HRTX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)